NuvOx Therapeutics Cash Flow Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year Ending	TTM	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024
Net Income	-11.19	-17.21	-7.27
Depreciation & Amortization	0.12	0.12	0.11
Share-Based Compensation	-	0.24	0.04
Other Operating Activities	9.29	14.16	2.76
Operating Cash Flow	-1.78	-2.07	-3.74
Capital Expenditures	0	-	-0.01
Change in Investments	-	-	1.4
Investing Cash Flow	0	-	1.39
Share Issuance / Repurchase	-	0.01	0.03
Debt Issued / Paid	-	0.93	1.34
Other Financing Activities	0.99	-0.39	-0.22
Financing Cash Flow	0.99	0.55	1.15
Net Cash Flow	-0.79	-1.53	-1.19
Free Cash Flow	-1.78	-2.07	-3.74
Free Cash Flow Margin	-171.88%	-211.33%	-730.86%